Biopharmaceutical CMO And CRO Market Report 2026

Biopharmaceutical CMO And CRO Market Overview

• Biopharmaceutical CMO And CRO market size has reached to $35.6 billion in 2025 • Expected to grow to $48.79 billion in 2030 at a compound annual growth rate (CAGR) of 6.4% • Growth Driver: Rising Research And Development Investment Fuels Growth In The Biopharmaceutical CMO And CRO Market • Market Trend: Strategic Partnerships Enhance Drug Development And Manufacturing In The Biopharmaceutical CMO and CRO Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Biopharmaceutical CMO And CRO Market?

Biopharmaceutical contract manufacturing organizations (CMO) and contract research organizations (CRO) are companies that provide outsourced services to biopharmaceutical firms. CMOs focus on the manufacturing and production of drugs, while CROs specialize in research and development, including clinical trials and regulatory support. Both help biopharmaceutical companies reduce costs and expedite the drug development process. The main types of biopharmaceuticals CMO and CRO products are biologics and biosimilars. Biologics are complex medicines made from living organisms used to treat various diseases, including cancer, autoimmune disorders, and infectious diseases. They provide various services, such as contract manufacturing and contract research, with different sources, including mammalian and non-mammalian.

What Is The Biopharmaceutical CMO And CRO Market Growth Forecast?

The biopharmaceutical cmo and cro market size is expected to see strong growth in the next few years. It will grow to $48.79 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increasing demand for advanced biologics manufacturing, rising investments in cell and gene therapies, expansion of global clinical trial pipelines, growing focus on speed-to-market strategies, increasing adoption of digitalized CRO services. Major trends in the forecast period include increasing outsourcing of biologic drug manufacturing, rising demand for end-to-end contract research services, growing focus on flexible manufacturing capacity, expansion of cell and gene therapy development support, enhanced emphasis on regulatory compliance services.

Global Biopharmaceutical CMO And CRO Market Segmentation

1) By Product: Biologics, Biosimilars 2) By Service Type: Contract Manufacturing, Contract Research 3) By Source: Mammalian, Non-Mammalian Subsegments: 1) By Biologics: Monoclonal Antibodies (mAbs), Vaccines, Recombinant Proteins, Cell and Gene Therapies, Antibody-Drug Conjugates (ADCs), Therapeutic Enzymes 2) By Biosimilars: Biosimilar Monoclonal Antibodies, Biosimilar Insulins, Biosimilar Growth Hormones, Biosimilar Erythropoietins, Biosimilar Granulocyte Colony-Stimulating Factors (G-CSFs)

What Is The Driver Of The Biopharmaceutical CMO And CRO Market?

The rising investment in research and development is expected to propel the growth of the biopharmaceutical CMO and CRO market going forward. Research and development investments are rising due to several factors, such as the demand for innovation, competitive pressures, the need to address evolving market needs, and government incentives. Research and development investments enable CMOs and CROs to create enhanced manufacturing methods and research procedures, hence improving their capabilities and operating efficiency. This drive to innovation draws in and maintains clients by providing cutting-edge solutions while still guaranteeing regulatory compliance. For instance, in September 2025, according to Eurostat, the Luxembourg-based statistical agency, the EU spent about $456 billion USD on research and development (R&D) in 2023 (€389 billion), and R&D expenditure relative to GDP rose to 2.26%, up from 2.22% in the previous year. Therefore, the rising investment in research and development is driving the growth of the biopharmaceutical CMO and CRO industry.

Key Players In The Global Biopharmaceutical CMO And CRO Market

Major companies operating in the biopharmaceutical cmo and cro market are Thermo Fisher Scientific Inc., Boehringer Ingelheim International GmbH, Eurofins Scientific SE, Lonza Group AG, Syneos Health Inc., Catalent Inc., Charles River Laboratories International Inc., Parexel International (MA) Corporation, Samsung Biologics Co. Ltd., CELLTRION INC., Medpace Holdings Inc., Fujifilm Diosynth Biotechnologies UK Limited, Almac Group, Pharmaron Beijing Co. Ltd., Worldwide Clinical Trials, KBI Biopharma, Inotiv Inc., Caidya, Rentschler Biopharma SE, Celerion Inc., TFS HEALTHCARE LIMITED

Global Biopharmaceutical CMO And CRO Market Trends and Insights

Major companies in the biopharmaceutical CMO and CRO market are forming strategic partnerships to enhance services, improve efficiencies, and accelerate drug development for biopharmaceutical firms. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in June 2024, Abzena plc., a UK-based biopharmaceutical company, partnered with Argonaut Manufacturing Services Inc., a US-based contract manufacturing organization (CMO), to integrate drug development and manufacturing solutions for clients. With this partnership, they aim to provide accelerated, end-to-end drug development and manufacturing solutions that enhance efficiency, reduce costs, and streamline biopharmaceutical production for clients.

What Are Latest Mergers And Acquisitions In The Biopharmaceutical CMO And CRO Market?

In June 2024, Great Point Partners, a US-based investment firm, acquired Lyocontract GmbH for an undisclosed amount. The acquisition allows Great Point Partners to broaden Lyocontract's contract manufacturing capabilities, including aseptic liquid filling, freeze-drying, and injectable medicine packaging. Lyocontract GmbH is a Germany-based drug product contract development and manufacturing organization (CDMO).

Regional Outlook

North America was the largest region in the biopharmaceutical CMO and CRO market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Biopharmaceutical CMO And CRO Market?

The biopharmaceutical CMO and CRO market includes revenues earned by entities by providing services such as formulation development, quality control and assurance, clinical trial management, data management, and analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Biopharmaceutical CMO And CRO Market Report 2026?

The biopharmaceutical cmo and cro market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the biopharmaceutical cmo and cro industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.